Results
Blog Post
The Global Burden of Disease (GBD) Study is the most ambitious effort to date to quantify the world’s health status. Involving 486 collaborators from 302 institutions in 50 countries, the study has been compared to the Human Genome Project in terms of potential impact. But health experts have criticized it as nontransparent and lacking accountability. What role will the GBD Study play in global health policymaking - and how can it be improved?
Big Data = Better Global Health?: What impact will the Global Burden of Disease study have?Blog Post
As we’ve seen in Ashoka Changemakers’ Nutrients for All campaign, there are several markets involved in bringing nutrient products to consumers. Interventions in these different markets can have a major impact, starting at the earliest stages in a product’s development, and they often involve multiple partners. This post, the second in a two-part series, shows how these interventions work in practice.
Shaping a Market for Nutrient Economies – Part 2: The value of partnerships
Blog Post
The concept of supply and demand seems pretty straightforward: consumers have a need, companies compete to meet it, and prices settle at a point where supply matches demand. But what happens when a clear need for a product doesn’t spark a thriving market? WDI’s Lisa Smith examines this conundrum as it relates to zinc treatment for diarrhea - and outlines supply-side interventions that could help.
Shaping a Market for Nutrient Economies – Part 1: The zinc conundrumNews
Secretary-General Ban Ki-moon has called on the global public health academic community to be active partners in the future development framework as the international community starts to set its post-2015 anti-poverty goals.
Ban tells public health educators to get involved in post-2015 development agendaNews
Comic Relief started as a response to the 1984 famine in Ethiopia. Any solution to the persisting problem of global hunger must factor in immunization.
Connecting the dots between vaccines and hungerBlog Post
In BoP countries, 70 to 90 percent of all childhood illness and death is caused by infectious diseases that can be treated with inexpensive drugs. But getting those drugs into the hands of patients is a daunting challenge. The HealthStore Foundation may have found a solution, through a micro-franchising model that has established a network of pharmacies and clinics in Kenya. Greg Starbird, the organization’s CEO, discusses the model and its challenges and successes.
The BoP Needs Drugs: Can the HealthStore Foundation’s model deliver?Blog Post
The 4th annual Indian Philanthropy Forum by Dasra, as usual, brought together philanthropists and investors to discuss trending social issues in India today and brainstorm effective ways of engagement with the social and social enterprise sectors. This year a salient theme emerged through every session: the empowerment of adolescent girls.
Indian Philanthropy Forum 2013 Focuses on Adolescent Girls, USAIDBlog Post
As countries struggle with deficits and debt, foreign aid often ends up on the chopping block. In response, UNITAID has developed an innovative model that raises funds for development aid from micro-taxes on business activity. It uses those funds - and market-based interventions - to increase BoP countries’ access to essential drugs and diagnostics. In this interview, UNITAID Chair Philippe Douste-Blazy discusses the organization’s funding and drug accessibility innovations.
Vive la France!: Has UNITAID unlocked the secret to sustainable foreign aid?
